Medical University Vienna
Vienna, 1090, Austria
NCT Number: NCT01585909
The purpose of this study is to evaluate the role of several enzymes of the gut mucosa in preventing invasion of gastrointestinal bacteria.
Looking for future studies?
Notify Me18 year–80 year
All sexes
Interventional
Not applicable
Vienna, 1090, Austria
Systemic Inflammatory Response Syndrome (SIRS), sepsis, septic shock and concomitant multiorgan failure are major causes of morbidity and mortality in intensive care units. During SIRS and septic shock the role of the gut seems to be uncertain. As it serves as an intestinal barrier which allows the symbiotic relationship between man and enteric bacteria, increased gut permeability during critical illness is accused to promote sepsis. Brush border enzymes have the ability to detoxify lipopolysaccharides and prevent bacterial invasion across the gut mucosal barrier. A reduced brush border enzyme function could contribute to the gastrointestinal intolerance in critically ill patients, which is frequently observed. The aim of this study is to assess the influence of SIRS and septic shock on brush border enzyme morphology and function in men.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Septic Shock:
Recruitment and inclusion criteria
Exclusion criteria
SIRS:
Recruitment and inclusion criteria
Exclusion criteria
Healthy/controls:
Inclusion criteria
Exclusion criteria
When gastroscopy is indicated for clinical reasons, duodenal biopsies to determine the activity of the brush border membrane enzymes intestinal alkaline phosphatase, maltase and lactase, as well as assessing brush border morphology are taken
Time frame: at inclusion
Duodenal biopsies will be taken on day 0 (at inclusion) and will be subsequently frozen. Determination of enzyme activity will be done within 28 days.
Time frame: at inclusion
Duodenal biopsies will be taken on day 0 (at inclusion) and will be subsequently frozen. Determination of enzyme activity will be done within 28 days.
Time frame: at inclusion
Duodenal biopsies will be taken on day 0 (at inclusion) and will be subsequently frozen. Determination of enzyme activity will be done within 28 days.
Time frame: at inclusion
Duodenal biopsies will be taken on day 0 (at inclusion) and will be subsequently frozen. Determination of enzyme activity will be done within 28 days.
Time frame: at ICU discharge
only for groups "septic shock" and "SIRS"
Time frame: at hospital discharge
only for groups "septic shock" and "SIRS"
Time frame: 6 months after inclusion
Medical University of Vienna
Other
Evaluation of Intestinal Brush Border Enzyme Function in Patients With SIRS and Septic Shock Compared to Control Patients
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06394947
Critical Illness, Disease Attributes
Rozzano, Milan, Italy
View Trial DetailsNCT07369206
Acute Respiratory Distress Syndrome (ARDS), Acute Respiratory Failure
Erzurum, Turkey (Türkiye)
View Trial DetailsNCT05950984
Adult Children, Antibiotic Resistant Infection
London, United Kingdom
View Trial DetailsNCT06953297
Critical Illness, Critical Illness Sepsis, Severe
Trabzon, Turkey (Türkiye)
View Trial Details